HAL (France)
open access
The Switch from Reference Biologic Medicines to Biosimilars in France: The Perspective of Patients and Prescribers on Barriers and Needs
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow#411289
- The Branded Health Service Medicines (Costs) (Amendment) Regulations 2026 (2026)#278239
- Referral of Patients With Biological Abnormalities to an Emergency Department#1010272
- Exploring alternative funding mechanisms to improve patient access to innovative medicines.#160060
- Adapt to Translate – Adaptive Clinical Trials and Biomedical Innovation#742138
Record · ID 171623
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive